SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Daikaffil Chemicals India informs about financial results

12 Aug 2022 Evaluate
Daikaffil Chemicals India has informed that it enclosed a copy of Unaudited Financial Results for the Quarter ended 30.06.2022. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting held on 12.08.2022 (i.e., today). The company also enclosed ‘Limited Review Report’ dated 12.08.2022, issued by Statutory Auditors, NGST & Associates, Chartered Accountants, in respect of Unaudited Financial Results for the Quarter ended 30.06.2022. The results are attached at 'Annexure A'.

The above information is a part of company’s filings submitted to BSE.

Daikaffil Chemicals Share Price

45.01 -0.99 (-2.15%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 656.15
PI Industries 3036.95
Bayer CropScience 4852.90
Sharda Cropchem 1101.50
Sumitomo Chemical 446.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×